A patent applied product, Ferronemia is intended to provide a solution for Iron deficiency and Iron deficiency anemia in Chronic Kidney Disease Patients by increasing the systemic Iron level and hemoglobin level with its unique mechanism of action. This novel solution is a successful outcome of technical collaboration with Enavant Research, USA based research consultancy.

© Frimline 2017. All rights reserved.